THE MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, AND MODERNIZATION ACT OF 2003

Transcription

1 THE MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, AND MODERNIZATION ACT OF 2003 A Legislative History of P.L by Mike Welsh William S. Hein & Co., Inc Buffalo, New York 2007

2 ISBN Introduction, selection, and arrangement of materials 2007 William S. Hein & Co., Inc. All rights reserved. Printed in the United States of America This volume is printed on acid-free paper by William S. Hein & Co., Inc.

3 SUMMARY TABLE OF CONTENTS Preface Table of Documents In printed volumes and CD-ROM Overview Law Conference Report Committee Reports, 108th Congress Committee Reports, 107th Congress Committee Reports, 106th Congress Debate, 108th Congress Senate Amendments Submitted, 108th Congress Debate, 108th Congress (continued) Debate, 107th Congress Related Debate Debate, 106th Congress In CD-ROM only Selected Markup Documents 108th Congress Senate Finance Committee House Ways and Means Committee Related to H.R Related to H.R Related to H.R. 2596

4 Bills, 108th Congress Major Bills Other Bills Bills, 107th Congress Bills, 106th Congress Hearings, 108th Congress Hearings, 107th Congress Hearings, 106th Congress Miscellaneous Remarks by Members Presidential Remarks and Signing Statement Government Accountability Office Report Congressional Research Service Reports

5 TABLE OF DOCUMENTS Note: The core documents, the law, reports and debate are contained in printed volumes 1 through 5. Hearings, markup documents, committee prints and other material are provided, along with the core documents, in the searchable CD-ROM included with this history. VOLUME 1 Overview CRS Report for Congress: Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of Law Doc. No. 1 Pub. Law , Medicare Prescription Drug, Improvement, and Modernization Act of 2003, signed December 8, Conference Report Doc. No. 2 H. Rpt (conf. rpt. on H.R. 1), November 21, VOLUME 2 Committee Reports, 108th Congress Doc. No. 3 Doc. No. 4 Doc. No. 5 H. Rpt (H. Rules Comm. on H. Res. 299 providing for consideration on H.R. 1 and H.R. 2596), June 26, H. Rpt pt. 2 (H. Ways and Means Comm. on H.R. 2473, Med. Mod. Prescription Drug Act), July 15, H. Rpt pt.1 (H. Energy and Commerce Comm. on H.R. 2473, Med. Mod. Prescription Drug Act), June 25, 2003.

6 Doc. No. 6 H. Rpt (H. Ways and Means Comm. on H.R. 2351, Health Savings Accounts), June 25, Doc. No. 7 H. Rpt pt. 2 (H. Energy and Commerce Comm., on H.R. 810, regulatory relief, contracting flexibility), April 29, VOLUME 3 Committee Reports, 108th Congress (continued) Doc. No. 8 H. Rpt pt. 1 (H. Ways and Means Comm. on H.R. 810, regulatory relief, contracting flexibility), April 11, Committee Reports, 107th Congress Doc. No. 9 Doc. No. 10 Doc. No. 11 Doc. No. 12 Doc. No. 13 Doc. No. 14 Doc. No. 15 Doc. No. 16 H. Rpt (H. Rules Comm. providing for consideration of H.R. 4954), June 26, H. Rpt pt. 1 (H. Energy and Commerce Comm. on H.R (and H.R. 4985), Med. Mod. Prescription Drug Act, Title 1), June 26, H. Rpt pt. 1 (H. Energy and Commerce Comm., on H.R. 4988, relating to Medicare Part A), June 26, H. Rpt pt. 1 (H. Energy and Commerce Comm. on H.R. 4986, relating to Medicare Part B), June 26, H. Rpt (H. Energy and Commerce Comm. on H.R. 4991, relating to Medicaid DSH payments), June 26, H. Rpt (H. Energy and Commerce Comm. on H.R relating to implementing elect. prescription drug programs), June 26, H. Rpt (H. Energy and Commerce Comm. on H.R relating to creating a bipartisan commission on the future of Medicare), June 26, H. Rpt (H. Energy and Commerce Comm. on H.R. 4988, relating to Medicare Benefits Admin.), June 26, 2002.

7 Doc. No. 17 Doc. No. 18 Doc. No. 19 H. Rpt pt. 1 (H. Energy and Commerce Comm. on H.R. 4987, Medicare Parts A and B), June 26, H. Rpt pt. 1 (H. Energy and Commerce Comm. on H.R. 4962, relating to rural health care), June 26, H. Rpt pt. 1 (H. Ways and Means Comm. on H.R. 4954, relating to creating a voluntary prescription drug program), June 26, VOLUME 4 Committee Reports, 107th Congress (continued) Doc. No. 20 H. Rpt (H. Ways and Means Comm. on H.R relating to regulatory relief and contracting flexibility), November 13, Committee Reports, 106th Congress Doc. No. 21 Doc. No. 22 H. Rpt (H. Rules Comm. providing for consideration of H.R. 4680, Medicare RX 2000 Act), June 28, H. Rpt pt. 1 (H. Ways and Means Comm. on H.R. 4680, Medicare RX 2000 Act), June 27, Debate, 108th Congress Cite 2003 Congressional Record: 149 Cong. Rec. page (daily ed., date) Doc. No. 23 Doc. No. 24 Doc. No. 25 Doc. No. 26 House consideration and passage of of H. Res. 299 (rule), and H.R. 1, June 26, 27, 2003, pgs. H5952 H6256. Senate consideration of S. 1, June 16, 2003, pgs. S , S7941. Senate consideration of S. 1, June 17, 2003, pgs. S , Senate consideration of S. 1, June 18, 2003, S , S8165.

8 Doc. No. 27 Doc. No. 28 Doc. No. 29 Doc. No. 30 Doc. No. 31 Senate consideration of S. 1, June 19, 2003, S , S Senate consideration of S. 1, June 20, 2003, S , S8317. Senate consideration of S. 1, June 23, 2003, S , S8381. Senate consideration of S.1, June 24, 2003, S , S , S8478. Senate consideration of S.1, June 25, 2003, S , S8601. Doc. No. 32 Senate consideration and passage of S. 1, June 26, 2003, S , S , S , S Senate Amendments Submitted, 108th Congress Doc. No. 33 Doc. No. 34 Doc. No. 35 Doc. No. 36 Amdts. submitted, June 18, 2003, pgs. S Amdts. submitted, June 19, 2003, pgs. S Amdts. submitted, June 20, 2003, pgs. S Amdts. submitted, June 23, 2003, pgs. S VOLUME 5 Senate Amendments Submitted, 108th Congress (continued) Doc. No. 37 Amdts. submitted, June 24, 2003, pgs. S Doc. No. 38 Doc. No. 39 Amdts. submitted, June 25, 2003, pgs. S Amdts. submitted, June 26, 2003, pgs. S Debate, 108th Congress (continued) Cite 2003 Congressional Record: 149 Cong. Rec. page (daily ed., date) Doc. No. 40 Senate passage of H.R. 1 (text of S. 1 substituted), appointment of conferees, July 7, 2003, pgs. S8898 S8997.

9 Doc. No. 41 House disagreement to Senate amendment, appointment of conferees, July 14, 2003, p. H6658. Doc. No. 42 Conference report as printed in Cong. Rec., November 20, 2003, pgs. H Doc. No. 43 House passage of H. Res. 463 and conference report on H.R. 1, November 21, 2003, pgs. H Doc. No. 44 Senate consideration of conference report on H.R. 1, November 22, 2003, pgs. S , S Doc. No. 45 Senate consideration of conference report on H.R. 1, November 23, 2003, pgs. S Doc. No. 46 Senate consideration of conference report on H.R. 1, November 24, 2003, pgs. S , S Doc. No. 47 Senate consideration and passage of conference report on H.R. 1, November 25, 2003, pgs. S Debate, 107th Congress Cite 2002 Congressional Record: 148 Cong. Rec. page (daily ed., date) Doc. No. 48 House consideration and passage of of H. Res. 465 and H.R (Medicare Prescription Drug and Modernization Act of 2002), June 27, 2002, pgs. H Related Debate Doc. No. 49 Doc. No. 50 Doc. No. 51 Senate consideration of S. 812 (Greater Access to Affordable Pharmaceuticals Act), July 17, 2002, pgs. S Senate consideration and passage of S. 812 (Greater Access to Affordable Pharmaceuticals Act), July 31, 2002, pgs. S House pass. H.R (Medicare Regulatory and Contracting Reform Act), December 4, 2001, pgs. H , H

10 Debate, 106th Congress Cite 2000 Congressional Record: 146 Cong. Rec. page (daily ed., date) Doc. No. 52 House consideration and passage of of H. Res. 539 and H.R (Medicare RX 2000 Act:), June 28, 2000, pgs. H Note: The items that follow (numbers ) are contained in the full-text searchable CD-ROM included with this history. Selected Markup Documents 108th Congress Senate Finance Committee Doc. No. 53 Doc. No. 54 Doc. No. 55 Description of the Prescription Drug and Medicare Improvement Act of, May 17, 2003, Senate Finance Committee ( 20committee%20description% pdf). The Prescription Drug and Medicare Improvement Act of 2003, June 10, 2003, Senate Finance Committee ( finance.senate.gov/sitepages/leg/chairman%27s%20mark %20%20Final% pdf). Chairman s Modifications to: The Prescription Drug Modernization Act of 2003, June 10, 2003, Senate Finance Committee ( modif.pdf). House Ways and Means Committee Related to H.R Doc. No. 56 Medicare Prescription Drug and Modernization Act of 2003, June 19, 2003 Summary of H.R. 2473, House Ways and Means Committee ( media/pdf/hr2473/hr2473summary.pdf).

11 Doc. No. 57 Amendments to the Chairman s Amendment in the Nature of a Substitute to H.R Adopted in Committee During Markup ( hr2473adoptedamendments.pdf). Doc. No. 58 Amendment in the Nature of a Substitute to H.R Offered by Mr. Thomas, June 17, 2003 (Chairman s Mark) ( 82subst.pdf). Related to H.R Doc. No. 59 Description of the Chairman s Amendment I the Nature of a Substitute to H.R. 2351, the Health Savings Account Availability Act, scheduled for a markup on June 19, 2003, Joint Committee on Taxation, June 18, 2003, JCX Doc. No. 60 Amendment in the Nature of a Substitute to H.R Offered by Mr. Thomas, June 18, 2003 (Chairman s Mark) ( substitute.pdf). Related to H.R Doc. No. 61 Joint Tax Committee, Technical Explanation of H.R the Health Savings and Affordability Act of 2003, as passed by the House of Representatives June 30, 2003, JCX Major Bills Doc. No. 62 Bills, 108th Congress H.R. 1 (enacted bill) Medicare Prescription Drug and Modernization Act of 2003, as introduced by Rep. Hastert, June 25, Doc. No. 63 H.R. 1 as passed House, June 27, 2003.

12 Doc. No. 64 Doc. No. 65 Doc. No. 66 H.R (major bill) Medicare Prescription Drug and Modernization Act of 2003 as introduced by Rep. Thomas, June 16, 2003 (this legislation was folded into H.R. 1). H.R as reported, June 25, July 15, 2003 (this bill was folded into H.R. 1). S. 1 (major bill) Prescription Drug and Medicare Improv2003 as introduced by Sen. Frist, June 11, Doc. No. 67 S. 1 as reported, June 13, Doc. No. 68 S. 1 as passed Senate, June 27, Other Bills Doc. No. 69 H.R. 810 as introduced by Rep. Johnson, February 13, 2003 (regulatory relief, contracting flexibility). Doc. No. 70 Doc. No. 71 Doc. No. 72 H.R. 810 as reported April 11,29, 2003 (regulatory relief, contracting flexibility). H.R EMTALA Regulatory Improvement Act of 2003 as introduced by Rep Shadegg, March 20, H.R Health Savings Account Availability Act as introduced by Rep. Thomas, June 5, Doc. No. 73 H.R as reported, June 25, Doc. No. 74 H.R Safety Net Hospital Pharmacy Access Act of 2003 as introduced by Rep. Shadegg, June 10, Doc. No. 75 H.R Health Savings and Affordability Act of 2003 as introduced by Rep. Thomas, June 25, Doc. No. 76 Doc. No. 77 S. 581 as introduced by Sen. Wyden, March 10, 2003 (Cit. Health Care Work. Group). S. 636 as introduced by Sen. Collins, March 17, 2003 (home health care). Doc. No. 78 Introductory statement by Sen. Collins on S. 636, March 17, Doc. No. 79 S. 869 as introduced by Sen. Harkin, April 10, 2003 (mammography).

13 Doc. No. 80 Introductory statement by Sen. Harkin on S. 869, April 10, Doc. No. 81 S. 942 as introduced by Sen. Brownback, April 29, 2003 (rural hospital services). Doc. No. 82 Doc. No. 83 Introductory statement by Sen. Brownback on S. 942, April 29, S. 946 as introduced by Sen. Leahy, April 29, 2003 (antitrust enforcement, drugs). Doc. No. 84 Introductory statement by Sen. Leahy on S. 946, April 29, Doc. No. 85 S as introduced by Sen. Sununu, May 21, 2003 (outpatient vision services). Doc. No. 86 Introductory statement by Sen. Sununu on S. 1095, May 23, Doc. No. 87 Doc. No. 88 S as introduced by Sen. Kyl, June 5, 2003 (inpatient drug prices). S as introduced by Sen. Gregg, June 10, 2003 (access to affordable pharmacies). Bills, 107th Congress Doc. No. 89 H.R as introduced by Rep. Johnson, August 2, 2001 (regulatory relief, contracting flexibility). Doc. No. 90 Doc. No. 91 Introductory statement by Rep. Johnson on H. R. 2768, Aug. 3, H.R as reported November 13, 2001 (regulatory relief, contracting flexibility). Doc. No. 92 H.R as introduced by Rep. Paul, August 2, 2001 (MSA plans). Doc. No. 93 Introductory statement by Rep. Paul on H.R. 2802, August 3, Doc. No. 94 H.R as introduced by Rep. Johnson, December 4, 2001 (regulatory relief, contracting flexibility).

14 Doc. No. 95 H.R as passed House, December 4, Doc. No. 96 H.R as introduced by Rep. Johnson, June 18, 2002 (voluntary prescription drug program). Doc. No. 97 Doc. No. 98 Doc. No. 99 Introductory statement by Rep. Tauzin on H.R and H.R. 4962, June 20, H.R as reported, June 26, 2002 (voluntary prescription drug program). H.R as passed House, June 28, 2002 (voluntary prescription drug program). Doc. No. 100 H.R as introduced by Rep. Tauzin, June 19, 2002 (rural health care). No bill as reported was printed. Doc. No. 101 H.R as introduced by Rep. Tauzin, June 21, 2002 (prescription drug benefit). Doc. No. 102 H.R as reported June 26, 2002 (prescription drug benefit). Doc. No. 103 H.R as introduced by Rep. Tauzin, June 21, 2002 (MSA program). Doc. No. 104 H.R as reported June 26, 2002 (MSA program). Doc. No. 105 H.R as introduced by Rep. Tauzin, June 21, 2002 (payments outpatient services). Doc. No. 106 H.R as reported June 26, 2002 (payments outpatient services). Doc. No. 107 H.R as introduced by Rep. Tauzin, June 21, 2002 (home health care). No bill as reported was printed. Doc. No. 108 H.R as introduced by Rep. Tauzin, June 21, 2002 (Med. Ben. Admin.) No bill as reported was printed. Doc. No. 109 H.R as introduced by Rep. Tauzin, June 21, 2002 (elective prescription drug program grants). Doc. No. 110 H.R as reported June 26, 2002 (elective prescription drug program grants). Doc. No. 111 H.R as introduced by Rep. Tauzin, June 21, 2002 (revise hospital payments).

15 Doc. No. 112 H.R as reported June 26, 2002 (revise hospital payments). Doc. No. 113 H.R as introduced by Rep. Rangel, June 26, 2002 (Democratic alternative bill, prescription drug benefit). Doc. No. 114 Introductory statements by Reps. Rangel, Dingell and Stark on H.R. 5019, June 27, Doc. No. 115 S. 812 as introduced by Sens. Schumer and McCain, May 1, 2001 (access to affordable pharmacies). Doc. No. 116 Colloquies between Sens. Stabenow, Schumer, Kennedy, et al on S. 812, May 1 and 2, Doc. No. 117 S. 812 as reported July 11, 2002 (access to affordable pharmacies). Doc. No. 118 S. 812 as passed Senate, July 31, 2002 (access to affordable pharmacies). Doc. No. 119 S. 357 as introduced by Sen. Breaux, February 15, 2001 (Medicare improvement). Doc. No. 120 S. 358 as introduced by Sen. Breaux, February 15, 2001 (prescription drug benefit). Bills, 106th Congress Doc. No. 121 S as introduced by Sen. Breaux, November 9, 1999 (Medicare improvement). Doc. No. 122 Introductory statement by Sen. Breaux on S. 1895, November 9, Doc. No. 123 H.R as introduced by Rep. Thomas, June 15, 2000 (voluntary prescription drug program). Doc. No. 124 H.R as reported, June 15, 27, 2000 (voluntary prescription drug program). Doc. No. 125 H.R as passed House, June 28, 2000 (voluntary prescription drug program).

16 Hearings, 108th Congress Doc. No. 126 President s FY 2004 Budget for U.S. Dept of HHS, Hearing Before the Committee on Ways and Means, House of Representatives, February 6, 2003, Ser Doc. No. 127 Medicare Regulatory and Contracting Reform, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representative, February 13, 2003, Ser Doc. No. 128 Eliminating Barriers to Chronic Care Management in Medicare, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representative, February 25, 2003, Ser Doc. No. 129 Medpac Report on Medicare Payment, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representative, March 6, 2003, Ser Doc. No. 130 Examining the Administration s Fiscal Year 2004 Health Care Priorities, Committee on Finance, United States Senate, February 27, 2003, S. Hrg Doc. No. 131 Purchasing Health Care Services in a Competitive Environment, Committee on Finance, United States Senate, April 3, 2003, S. Hrg Doc. No. 132 Designing a Twenty-First Cent. Medicare Prescription Drug Benefit, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, April 8, 2003, Ser Doc. No. 133 Examining the House and Senate Versions of the Greater Access to Afford. Pharmaceuticals Act, Hearing Before the Committee on the Judiciary, United States Senate, August 1, 2003, Ser. J , S. Hrg Doc. No. 134 Strengthening and Improving Medicare, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, April 9, 2003, Ser

17 Doc. No. 135 Medicare Cost-Sharing and Medigap, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representative, May 1, 2003, Ser Doc. No. 136 Strengthening and Improving the Medicare Program, Committee on Finance, United States Senate, June 6, 2003, S. Hrg Hearings, 107th Congress Doc. No. 137 Medicare Reform: Prov. Prescription Drug Coverage for Seniors, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, February 15, 2001, Ser.10 Doc. No. 138 Medicare Reform, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, February 28, 2001, Ser Doc. No. 139 Bush Administration s Health and Welfare Priorities, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, March 14, 2001, Ser Doc. No. 140 Second in Series on Medicare Reform: Bring. Reg. Relief to Beneficiaries Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, March 15, 2001, Ser Doc. No. 141 Third in Series on Medicare Reform: Laying Groundwork for an RX Drug Benefit, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives March 27, 2001, Ser Doc. No. 142 Social Security and Medicare Trustees 2001 Annual Reports, Joint Hearing Before the Committee on Ways and Means, House of Representatives and Committee on Finance, United States Senate, March 20, 2001, Ser Doc. No. 143 Medicare Solvency, Hearing Before the Committee on Ways and Means, House of Representatives, March 20, 2001, Ser

18 Doc. No. 144 Fourth in Series on Medicare Reform: Medicare + Choice: Lessons for Reform, Hearing Before the Committee on Ways and Means, House of Representatives March 20, 2001, May 1, 2001, Ser Doc. No. 145 Fifth in Series on Medicare Reform: Strengthening Medicare: Mod. Beneficiary Cost Sharing, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, May 9, 2001, Ser Doc. No. 146 Medicare Reform: Providing Prescription Drug Coverage for Seniors, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, May 16, 2001, Ser Doc. No. 147 Has Medicare + Choice Reduced Variation in the Premiums and Benefits Offered by Participating Health Plans? A Rev. of Medicare + Choice Plan Payment Methodology, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, May 31, 2001, Ser Doc. No. 148 Rural Health Care in Medicare, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, June 12, 2001, Ser Doc. No. 149 Medicare Reform: Modernizing Medicare and Merging. Parts. A and B, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, June 14, 2001, Ser Doc. No. 150 Administration s Principles to Strengthen and Modernize Medicare, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, July 19, 2001, Ser Doc. No. 151 Modernizing Medicare, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, July 26, 2001, Ser Doc. No. 152 H.R. 2768, Medicare Regulatory and Contracting Reform Act of 2002, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, September 25, 2001, Ser

19 Doc. No. 153 Status of Medicare + Choice Program, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives December 4, 2001, Ser Doc. No. 154 President s 2003 Budget Proposals Featuring HHS Secretary Thompson, Hearing Before the Committee on Ways and Means, House of Representatives February 6, 2002, Ser Doc. No. 155 Medicare Payment Policy: Ensuring Stability and Access Through Physician Payments. Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, February 14, 2002, Ser Doc. No. 156 Physician Payments, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, February 28, 2002, Ser Doc. No. 157 Administration s. FY 2003 Budget Proposal. for Presc. Drugs, Hearing before the Committee on Finance, United States Senate, March 7, 2002, S. Hrg Doc. No. 158 Health Quality and Medical Errors, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, March 7, 2002, Ser Doc. No. 159 Reimbursement and Access to Presc. Drugs Under Medicare Part B, Hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate March 14, 2002, S. Hrg Doc. No. 160 Medicare Supplemental Insurance, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, March 14, 2002, Ser Doc. No. 161 Medicare Modernization: Examining Federal Employee Health Benefits Program as a Model for Seniors, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, March 20, 2002, Ser

20 Doc. No. 162 Promoting Disease Management in Medicare, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, April 16, 2002, Ser Doc. No. 163 Integrating Prescription Drugs into Medicare, Hearing Before the Committee on Ways and Means, House of Representatives, April 17, 2002, Ser Doc. No. 164 Medicare s Geographic Cost Adjustors, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representative, July 23, 2002, Ser Doc. No. 165 Medicare Payments for Currently Covered Prescription Drugs, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representative, October 3, 2002, Ser Hearings, 106th Congress Doc. No. 166 Prescription Drugs: What We Know and Don t Know About Seniors Access to Coverage, Hearings Before the Subcommittee on Health, Committee on Commerce, House of Representatives, September 28, October 4, 1999, Ser Doc. No. 167 Seniors Access to Prescription Drug Benefits, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, February 15, 2000, Ser Doc. No. 168 Seniors Access to Affordable Prescription Drugs: Models for Reform, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, February 16, 2000, Ser Doc. No. 169 Administration s. Presc. Drug Proposal, Hearing Before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, May 11, 2000, Ser Doc. No. 170 Legislation to Cover Prescription Drugs Under Medicare, Hearing Before the Committee on Ways and Means, House of Representatives, June 13, 2000, Ser

21 Doc. No. 171 Prescription Drugs: Mod. Medicare for the 21st Century, Hearing Before the Subcommittee on Health, Committee on Commerce, House of Representatives, June 14, 2000, Ser Miscellaneous Remarks by Members Cite 2003 Congressional Record: 149 Cong. Rec. page (daily ed., date) Doc. No. 172 Miscellaneous remarks by members from the Congressional Record, 108th Congress. Presidential Remarks and Signing Statement Doc. No. 173 Remarks on Signing the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, December 8, 2003, Vol. 39, No. 49, Weekly Compilation of Presidential Documents pgs Doc. No. 174 Statement on Signing the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, December 8, 2003,Vol. 39, No. 49, Weekly Compilation of Presidential Documents p Government Accountability Office Report Doc. No. 175 GAO , Prescription Drug Discount Cards: Savings Depend on Pharmacy and Type of Card Used, September 2003, September United States General Accounting Office, Washington, D.C. Congressional Research Service Reports Doc. No. 176 CRS RL31525 Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation, July 25, Doc. No. 177 CRS RL31992 Medicare Prescription Drug Provisions of S.1 as passed the Senate and H.R.1 as passed the House, July 11, 2003.